• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与人类免疫缺陷病毒相关的恶病质:潜在机制与治疗

HIV-related cachexia: potential mechanisms and treatment.

作者信息

Von Roenn J H, Roth E L, Craig R

机构信息

Department of Medicine, Northwestern University Medical School, Chicago, Ill.

出版信息

Oncology. 1992;49 Suppl 2:50-4. doi: 10.1159/000227129.

DOI:10.1159/000227129
PMID:1461629
Abstract

Involuntary weight loss or wasting indicative of severe protein energy malnutrition is a frequent complication of acquired immune deficiency syndrome (AIDS). Malnutrition, with its associated adverse effects on immunocompetence, may contribute to the progression of AIDS itself. Since death from wasting is ultimately related to the magnitude of tissue depletion, restoration of body cell mass may enhance survival. The mechanism of weight loss in AIDS has not been clearly elucidated. The etiology is likely to be multifactorial, the result of interactions between decreased caloric intake, malabsorption, and alterations in energy expenditure secondary to hormonal and/or metabolic abnormalities. Although weight loss is occasionally reversible with treatment of underlying infections and/or easily identifiable and reversible causes, the majority of patients are not this fortunate. Enteral and parenteral nutrition, which are expensive, cumbersome, and potentially morbid, have been suggested by some as therapeutic options. Megestrol acetate, a synthetic, orally active progestational agent, has been reported to stimulate appetite and weight gain. Data regarding the use of megestrol acetate for the treatment of cachexia related to human immunodeficiency virus (HIV) infection demonstrate convincingly its effectiveness in treating many patients with HIV-related anorexia and cachexia.

摘要

非自愿性体重减轻或消瘦是获得性免疫缺陷综合征(AIDS)常见的并发症,提示严重的蛋白质能量营养不良。营养不良及其对免疫功能的相关不良影响,可能会促使艾滋病病情进展。由于消瘦导致的死亡最终与组织消耗程度相关,恢复体细胞量可能会提高生存率。艾滋病患者体重减轻的机制尚未完全阐明。病因可能是多因素的,是热量摄入减少、吸收不良以及激素和/或代谢异常继发的能量消耗改变之间相互作用的结果。虽然通过治疗潜在感染和/或易于识别和可逆的病因,体重减轻偶尔是可逆的,但大多数患者没有这么幸运。肠内和肠外营养费用昂贵、操作繁琐且有潜在风险,一些人建议将其作为治疗选择。醋酸甲地孕酮是一种合成的口服活性孕激素,据报道可刺激食欲并增加体重。关于使用醋酸甲地孕酮治疗与人类免疫缺陷病毒(HIV)感染相关恶病质的数据令人信服地证明了其对许多HIV相关厌食和恶病质患者的有效性。

相似文献

1
HIV-related cachexia: potential mechanisms and treatment.与人类免疫缺陷病毒相关的恶病质:潜在机制与治疗
Oncology. 1992;49 Suppl 2:50-4. doi: 10.1159/000227129.
2
Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia.醋酸甲地孕酮治疗艾滋病相关厌食和恶病质的随机试验。
Oncology. 1994 Oct;51 Suppl 1:19-24. doi: 10.1159/000227411.
3
Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection.醋酸甲地孕酮用于治疗与人类免疫缺陷病毒感染相关的厌食和恶病质。
Semin Oncol. 1990 Dec;17(6 Suppl 9):13-6.
4
Treatment of anorexia with megestrol acetate.醋酸甲地孕酮治疗厌食症。
Nutr Clin Pract. 1993 Jun;8(3):115-8. doi: 10.1177/0115426593008003115.
5
Megestrol acetate in patients with AIDS-related cachexia.醋酸甲地孕酮用于艾滋病相关性恶病质患者。
Ann Intern Med. 1994 Sep 15;121(6):393-9. doi: 10.7326/0003-4819-121-6-199409150-00001.
6
Megestrol acetate in patients with AIDS and cachexia.醋酸甲地孕酮用于艾滋病和恶病质患者。
Ann Intern Med. 1994 Sep 15;121(6):400-8. doi: 10.7326/0003-4819-121-6-199409150-00002.
7
Megestrol for AIDS-related anorexia.
Ann Intern Med. 1995 Jun 1;122(11):880; author reply 881. doi: 10.7326/0003-4819-122-11-199506010-00016.
8
Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection.
Ann Intern Med. 1988 Nov 15;109(10):840-1. doi: 10.7326/0003-4819-109-10-840.
9
Megestrol acetate and cachexia associated with human immunodeficiency virus (HIV) infection.
Ann Intern Med. 1989 Apr 15;110(8):667-8. doi: 10.7326/0003-4819-110-8-667.
10
Weight gain in patients with AIDS-related cachexia: is bigger better?
Ann Intern Med. 1994 Sep 15;121(6):462-3. doi: 10.7326/0003-4819-121-6-199409150-00011.

引用本文的文献

1
Plasma metabolomics by nuclear magnetic resonance reveals biomarkers and metabolic pathways associated with the control of HIV-1 infection/progression.通过核磁共振进行的血浆代谢组学揭示了与HIV-1感染/进展控制相关的生物标志物和代谢途径。
Front Mol Biosci. 2023 Jun 29;10:1204273. doi: 10.3389/fmolb.2023.1204273. eCollection 2023.
2
Change in Nutritional and Biochemical Status in People Living with HIV-1 on Antiretroviral Therapy.抗逆转录病毒治疗的 HIV-1 感染者营养和生化状态的变化。
Viruses. 2022 Nov 20;14(11):2573. doi: 10.3390/v14112573.
3
Low Dehydroepiandrosterone (DHEA) Level Is Associated with Poor Immunologic Response among People Living with HIV/AIDS.
低脱氢表雄酮(DHEA)水平与艾滋病毒/艾滋病感染者免疫反应不佳有关。
J Clin Med. 2022 Oct 14;11(20):6077. doi: 10.3390/jcm11206077.
4
IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health.在接受抗逆转录病毒治疗的 SIV 感染期间阻断 IFN-α 会降低组织 vDNA,挽救免疫功能,并改善整体健康状况。
JCI Insight. 2022 Mar 8;7(5):e153046. doi: 10.1172/jci.insight.153046.
5
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia.癌症恶病质及其病理生理学:与肌肉减少症、厌食症和乏力的关系。
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):619-635. doi: 10.1002/jcsm.12528. Epub 2020 Mar 6.
6
Hypothalamic Inflammation at a Crossroad of Somatic Diseases.下丘脑炎症:躯体疾病的十字路口
Cell Mol Neurobiol. 2019 Jan;39(1):11-29. doi: 10.1007/s10571-018-0631-4. Epub 2018 Oct 30.
7
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.下丘脑功能障碍与多发性硬化症:对疲劳和体重调节异常的影响
Curr Neurol Neurosci Rep. 2016 Nov;16(11):98. doi: 10.1007/s11910-016-0700-3.
8
Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients.晚期非小细胞肺癌患者的恶病质指数
Clin Med Insights Oncol. 2015 Nov 9;9:87-93. doi: 10.4137/CMO.S30891. eCollection 2015.
9
Behavioral medicine interventions can improve the quality-of-life and health of persons with HIV disease.行为医学干预可以改善 HIV 感染者的生活质量和健康。
Ann Behav Med. 1996 Mar;18(1):40-8. doi: 10.1007/BF02903938.
10
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia.口服活性黑皮质素-4受体拮抗剂BL-6020/979:治疗癌症恶病质的有前景候选药物。
J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):163-174. doi: 10.1007/s13539-011-0039-1. Epub 2011 Aug 28.